References
Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB (2013). Understanding type 1 diabetes: etiology and models. Canadian journal of diabetes37 (4): 269-276.
An X, Zhang L, Yao Q, Li L, Wang B, Zhang J, et al. (2018). The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-kappaB signaling pathway. Molecular and cellular endocrinology 470: 14-25.
An XF, Zhou L, Jiang PJ, Yan M, Huang YJ, Zhang SN, et al.(2011). Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.Molecular and cellular biochemistry 354 (1-2):47-55.
Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I (2006). Tumor suppressor p53 regulates heparanase gene expression. Oncogene25 (28): 3939-3947.
Chen F, Sha M, Wang Y, Wu T, Shan W, Liu J, et al. (2016). Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.Diabetologia 59 (2): 316-324.
Choong FJ, Freeman C, Parish CR, Simeonovic CJ (2015). Islet heparan sulfate but not heparan sulfate proteoglycan core protein is lost during islet isolation and undergoes recovery post-islet transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15 (11): 2851-2864.
Courtney SM, Hay PA, Buck RT, Colville CS, Phillips DJ, Scopes DI, et al. (2005). Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorganic & medicinal chemistry letters 15 (9): 2295-2299.
Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, et al. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol 175 (7): 987-993.
Dai X, Yan J, Fu X, Pan Q, Sun D, Xu Y, et al. (2017). Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.Clinical cancer research : an official journal of the American Association for Cancer Research 23 (20): 6267-6278.
David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H (1992). Developmental changes in heparan sulfate expression: in situ detection with mAbs. The Journal of cell biology119 (4): 961-975.
de Mestre AM, Rao S, Hornby JR, Soe-Htwe T, Khachigian LM, Hulett MD (2005). Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells. The Journal of biological chemistry280 (42): 35136-35147.
Deshpande AS, Ramireddy S, Sudandiradoss C, Noor A, Sen P (2019). Streptozocin; a GLUT2 binding drug, interacts with human serum albumin at loci h6DOM3-h7DOM3. International journal of biological macromolecules 128: 923-933.
Dong J, Kukula AK, Toyoshima M, Nakajima M (2000). Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 253 (2): 171-178.
Edge AS, Spiro RG (2000). A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.Diabetologia 43 (8): 1056-1059.
Ferris ST, Carrero JA, Mohan JF, Calderon B, Murphy KM, Unanue ER (2014). A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity 41 (4): 657-669.
Ginath S, Lurie S, Golan A, Amsterdam A, Sandbank J, Sadan O, et al. (2015). The expression of heparanase in normal and preeclamptic placentas. J Matern Fetal Neonatal Med 28 (13):1589-1593.
Han J, Woytowich AE, Mandal AK, Hiebert LM (2007). Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin. Experimental biology and medicine232 (7): 927-934.
Han X, Sun Y, Scott S, Bleich D (2001). Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes50 (5): 1047-1055.
Hao NB, Tang B, Wang GZ, Xie R, Hu CJ, Wang SM, et al. (2015). Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-kappaB signaling pathway for gastric cancer metastasis.Cancer letters 361 (1): 57-66.
Hu J, Wang J, Leng X, Hu Y, Shen H, Song X (2017). Heparanase mediates vascular endothelial growth factor gene transcription in high-glucose human retinal microvascular endothelial cells. Molecular vision23: 579-587.
Iozzo RV (1998). Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609-652.
Irving-Rodgers HF, Ziolkowski AF, Parish CR, Sado Y, Ninomiya Y, Simeonovic CJ, et al. (2008). Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia 51 (9): 1680-1688.
Lawlor N, George J, Bolisetty M, Kursawe R, Sun L, Sivakamasundari V, et al. (2017). Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res 27 (2): 208-222.
Li K, Qiu C, Sun P, Liu DC, Wu TJ, Wang K, et al. (2019). Ets1-Mediated Acetylation of FoxO1 Is Critical for Gluconeogenesis Regulation during Feed-Fast Cycles. Cell reports26 (11): 2998-3010 e2995.
Lin HY, Yin Y, Zhang JX, Xuan H, Zheng Y, Zhan SS, et al. (2012). Identification of direct forkhead box O1 targets involved in palmitate-induced apoptosis in clonal insulin-secreting cells using chromatin immunoprecipitation coupled to DNA selection and ligation.Diabetologia 55 (10): 2703-2712.
Lin M, Yin N, Murphy B, Medof ME, Segerer S, Heeger PS, et al.(2010). Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes59 (9): 2247-2252.
Lombardi A, Tsomos E, Hammerstad SS, Tomer Y (2018). Interferon alpha: The key trigger of type 1 diabetes. Journal of autoimmunity94: 7-15.
Lu WC, Liu YN, Kang BB, Chen JH (2003). Trans-activation of heparanase promoter by ETS transcription factors. Oncogene22 (6): 919-923.
Mallone R, Brezar V, Boitard C (2011). T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.Clinical & developmental immunology 2011: 513210.
Mao Y, Huang Y, Buczek-Thomas JA, Ethen CM, Nugent MA, Wu ZL, et al. (2014). A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.The Journal of biological chemistry 289 (49):34141-34151.
Masola V, Granata S, Bellin G, Gambaro G, Onisto M, Rugiu C, et al. (2017). Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association32 (7): 1145-1154.
Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D, Jr., Gattuso P, et al. (2005). Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes54 (7): 2172-2178.
Noble JA (2015). Immunogenetics of type 1 diabetes: A comprehensive review. J Autoimmun 64: 101-112.
Noguchi H, Ueda M, Matsumoto S, Kobayashi N, Hayashi S (2007). BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans. Human gene therapy 18 (1): 10-17.
Oskarsson ME, Singh K, Wang J, Vlodavsky I, Li JP, Westermark GT (2015). Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis. The Journal of biological chemistry 290 (24): 15121-15132.
Qu H, Zheng L, Jiao W, Mei H, Li D, Song H, et al. (2016). Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase. Scientific reports6: 32628.
Rao G, Ding HG, Huang W, Le D, Maxhimer JB, Oosterhof A, et al.(2011). Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis. Diabetologia 54 (6): 1527-1538.
Rivara S, Milazzo FM, Giannini G (2016). Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases. Future medicinal chemistry 8 (6):647-680.
Shafat I, Ilan N, Zoabi S, Vlodavsky I, Nakhoul F (2011). Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels. PloS one6 (2): e17312.
Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn LJ, Rosenthal B, et al. (2019). A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets.Cell 176 (4): 790-804 e713.
Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, et al. (2012). PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. British journal of cancer 106 (9):1486-1494.
Simeonovic CJ, Popp SK, Starrs LM, Brown DJ, Ziolkowski AF, Ludwig B, et al. (2018). Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans. PloS one 13 (2): e0191360.
Simeonovic CJ, Ziolkowski AF, Wu Z, Choong FJ, Freeman C, Parish CR (2013). Heparanase and autoimmune diabetes. Frontiers in immunology 4: 471.
So WY, Cheng Q, Chen L, Evans-Molina C, Xu A, Lam KS, et al.(2013). High glucose represses beta-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor gamma signaling. Diabetes 62 (11): 3751-3759.
Sun P, Wang T, Chen L, Yu BW, Jia Q, Chen KX, et al. (2016). Trimer procyanidin oligomers contribute to the protective effects of cinnamon extracts on pancreatic beta-cells in vitro. Acta pharmacologica Sinica 37 (8): 1083-1090.
Sun P, Zhu JJ, Wang T, Huang Q, Zhou YR, Yu BW, et al. (2018). Benzbromarone aggravates hepatic steatosis in obese individuals.Biochimica et biophysica acta. Molecular basis of disease1864 (6 Pt A): 2067-2077.
Takahashi I, Noguchi N, Nata K, Yamada S, Kaneiwa T, Mizumoto S, et al. (2009). Important role of heparan sulfate in postnatal islet growth and insulin secretion. Biochem Biophys Res Commun383 (1): 113-118.
Theodoraki A, Hu Y, Poopalasundaram S, Oosterhof A, Guimond SE, Disterer P, et al. (2015). Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulation.Mol Cell Endocrinol 399: 296-310.
Ueda M, Matsumoto S, Hayashi S, Kobayashi N, Noguchi H (2008). Cell surface heparan sulfate proteoglycans mediate the internalization of PDX-1 protein. Cell transplantation 17 (1-2):91-97.
Whitehead MJ, McGonigal R, Willison HJ, Barnett SC (2018). Heparanase attenuates axon degeneration following sciatic nerve transection.Sci Rep 8 (1): 5219.
Xin Y, Kim J, Okamoto H, Ni M, Wei Y, Adler C, et al. (2016). RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes.Cell Metab 24 (4): 608-615.
Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL (2003). The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. Pancreas26 (4): e99-104.
Zhu H, Carpenter RL, Han W, Lo HW (2014). The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth. Cancer letters343 (1): 51-61.
Ziolkowski AF, Popp SK, Freeman C, Parish CR, Simeonovic CJ (2012). Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes. The Journal of clinical investigation 122 (1): 132-141.